image
Energy - Oil & Gas Equipment & Services - NYSE - NL
$ 11.7
-2.16 %
$ 549 M
Market Cap
19.98
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one CLB stock under the worst case scenario is HIDDEN Compared to the current market price of 11.7 USD, Core Laboratories N.V. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one CLB stock under the base case scenario is HIDDEN Compared to the current market price of 11.7 USD, Core Laboratories N.V. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one CLB stock under the best case scenario is HIDDEN Compared to the current market price of 11.7 USD, Core Laboratories N.V. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CLB

image
$22.0$22.0$20.0$20.0$18.0$18.0$16.0$16.0$14.0$14.0$12.0$12.0$10.0$10.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
524 M REVENUE
2.76%
58.6 M OPERATING INCOME
7.17%
32.2 M NET INCOME
-13.16%
56.4 M OPERATING CASH FLOW
127.47%
-6.39 M INVESTING CASH FLOW
3.88%
-46 M FINANCING CASH FLOW
-149.16%
124 M REVENUE
-4.37%
4.42 M OPERATING INCOME
-68.84%
69 K NET INCOME
-99.08%
6.66 M OPERATING CASH FLOW
-67.69%
772 K INVESTING CASH FLOW
121.69%
-4.48 M FINANCING CASH FLOW
76.86%
Balance Sheet Core Laboratories N.V.
image
Current Assets 227 M
Cash & Short-Term Investments 19.2 M
Receivables 127 M
Other Current Assets 80.1 M
Non-Current Assets 364 M
Long-Term Investments 5.08 M
PP&E 154 M
Other Non-Current Assets 205 M
3.24 %21.57 %13.57 %26.01 %34.75 %Total Assets$590.4m
Current Liabilities 97.6 M
Accounts Payable 34.5 M
Short-Term Debt 10.7 M
Other Current Liabilities 52.3 M
Non-Current Liabilities 235 M
Long-Term Debt 169 M
Other Non-Current Liabilities 65.6 M
10.39 %3.21 %15.74 %50.94 %19.73 %Total Liabilities$332.7m
EFFICIENCY
Earnings Waterfall Core Laboratories N.V.
image
Revenue 524 M
Cost Of Revenue 435 M
Gross Profit 88.4 M
Operating Expenses 29.8 M
Operating Income 58.6 M
Other Expenses 26.4 M
Net Income 32.2 M
600m600m500m500m400m400m300m300m200m200m100m100m00524m(435m)88m(30m)59m(26m)32mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
16.87% GROSS MARGIN
16.87%
11.18% OPERATING MARGIN
11.18%
5.99% NET MARGIN
5.99%
12.46% ROE
12.46%
5.32% ROA
5.32%
8.08% ROIC
8.08%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Core Laboratories N.V.
image
200m200m180m180m160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 32.2 M
Depreciation & Amortization 15 M
Capital Expenditures -13 M
Stock-Based Compensation 3.76 M
Change in Working Capital 7.88 M
Others -5.03 M
Free Cash Flow 43.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Core Laboratories N.V.
image
Wall Street analysts predict an average 1-year price target for CLB of $23 , with forecasts ranging from a low of $17 to a high of $32 .
CLB Lowest Price Target Wall Street Target
17 USD 45.30%
CLB Average Price Target Wall Street Target
23 USD 96.58%
CLB Highest Price Target Wall Street Target
32 USD 173.50%
Price
Max Price Target
Min Price Target
Average Price Target
353530302525202015151010Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.07% DIVIDEND YIELD
0.01 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
2.50002.50002.00002.00001.50001.50001.00001.00000.50000.50000.00000.00000.550.550.550.550.550.250.550.550.550.550.550.550.550.550.550.550.552.200.552.200.552.200.552.200.552.200.280.040.040.040.040.022015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 13
6. Ownership
Insider Ownership Core Laboratories N.V.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Core Laboratories Q1 Earnings Miss Estimates, Expenses Increase YoY CLB's first-quarter earnings miss estimates due to the underperformance of the Reservoir Description segment. zacks.com - 3 weeks ago
Core Laboratories Inc. (CLB) Q1 2025 Earnings Call Transcript Core Laboratories Inc. (NYSE:CLB ) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Sean Mitchell - Daniel Energy Partners Operator Good day, and welcome to the Core Laboratories First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. seekingalpha.com - 3 weeks ago
New Strong Sell Stocks for April 24th AMPY, CARS and CLB have been added to the Zacks Rank #5 (Strong Sell) List on April 24, 2025. zacks.com - 3 weeks ago
Core Laboratories (CLB) Q1 Earnings and Revenues Lag Estimates Core Laboratories (CLB) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.19 per share a year ago. zacks.com - 3 weeks ago
CORE LAB REPORTS FIRST QUARTER 2025 RESULTS REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAR OPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEAR FREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON , April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,600,000. Core's operating income was $4,400,000, with earnings per diluted share ("EPS") of $0.00, all in accordance with U.S. generally accepted accounting principles ("GAAP"). prnewswire.com - 3 weeks ago
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch CLB's first-quarter revenues are likely to have declined from the year-ago period's level. However, cost reductions are expected to have provided modest relief. zacks.com - 4 weeks ago
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 month ago
Here's How to Play Core Labs Stock Ahead of Its Q1 Earnings Release CLB faces declining revenues, weak margins, geopolitical disruptions and inventory issues, with low dividend yield and overvaluation increasing investor caution. zacks.com - 1 month ago
CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. prnewswire.com - 1 month ago
Is Core Stock Worth Buying After a 27% Surge in 6 Months? CLB stock is supported by international expansion, proprietary tech and solid cash flow amid competitive pricing, volatile oil prices and geopolitical tensions. zacks.com - 2 months ago
Why Is Core Laboratories (CLB) Down 16% Since Last Earnings Report? Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? zacks.com - 2 months ago
CLB's Q4 Earnings Beat Estimates, Sales Lag, Expenses Increase Core Laboratories expects Reservoir Description revenues of $82-$85 million and Production Enhancement revenues of $39-$42 million for the first quarter of 2025. zacks.com - 3 months ago
8. Profile Summary

Core Laboratories N.V. CLB

image
COUNTRY NL
INDUSTRY Oil & Gas Equipment & Services
MARKET CAP $ 549 M
Dividend Yield 0.07%
Description Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Contact Van Heuven Goedhartlaan 7 B, Amstelveen, 1181 LE https://www.corelab.com
IPO Date Sept. 21, 1995
Employees 3400
Officers Mr. Lawrence V. Bruno Chairman of the Board, Chief Executive Officer, President & Chief Operating Officer Mr. Sow Hang Teo Vice President, Treasurer & Chief Accounting Officer Mr. Jacobus Schouten Managing Director J. Donald Dumas Jr. Senior Vice President of Production Enhancement & Business Development Ms. Gwendolyn Y. Gresham M.B.A. Senior Vice President of Corporate Development & Investor Relations Billy Anthony President of Owen Oil Tools Mr. Christopher Scott Hill Senior Vice President & Chief Financial Officer Mr. Mark Damian Tattoli Senior Vice President, Secretary & General Counsel Leslie D. Linklater Vice President People, Organization, & Culture